|
| Karenitecin Basic information |
Product Name: | Karenitecin | Synonyms: | Karenitecin;(4S)-4-Ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;BNP 1350;Cositecan;DB 172;MCC 12824;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-, (4S)- | CAS: | 203923-89-1 | MF: | C25H28N2O4Si | MW: | 448.59 | EINECS: | | Product Categories: | | Mol File: | 203923-89-1.mol | |
| Karenitecin Chemical Properties |
Boiling point | 727.2±60.0 °C(Predicted) | density | 1.29±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | Soluble in DMSO | form | Solid | pka | 11.27±0.20(Predicted) | color | Light yellow to yellow |
| Karenitecin Usage And Synthesis |
Uses | Karenitecin is a topoisomerase I inhibitor, with potent anti-cancer activity. | Definition | ChEBI: Cositecan is a pyranoindolizinoquinoline. |
| Karenitecin Preparation Products And Raw materials |
|